NCT00178971View on ClinicalTrials.gov

Serotonin 1A Agonists and Cognition in Schizophrenia

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

October 31, 2004

Study Completion Date

October 31, 2004

Conditions
SchizophreniaSchizoaffective Disorder
Interventions
DRUG

adjunctive treatment with buspirone

buspirone 15-30 mg qd

DRUG

placebo

placebo

Trial Locations (1)

37212

Psychiatric Hospital at Vanderbilt, Nashville

All Listed Sponsors
collaborator

National Alliance for Research on Schizophrenia and Depression

OTHER

lead

Northwestern University

OTHER

NCT00178971 - Serotonin 1A Agonists and Cognition in Schizophrenia | Biotech Hunter | Biotech Hunter